Articles by Ludwig Cancer Research

Patients with high TMC may generate more proinflammatory immune cells, and therefore, respond better to immunotherapy 

A new study addresses a central conundrum of CAR-T therapies: their tendency to provoke potentially deadly runaway immune responses against healthy tissues in patients